Harrington Investments, Inc Gilead Sciences, Inc. Transaction History

Harrington Investments, Inc

  • $181 Million
  • Q3 2024

A detailed history of Harrington Investments, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harrington Investments, Inc holds 21,377 shares of GILD stock, worth $1.99 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
21,377
Previous 21,907 2.42%
Holding current value
$1.99 Million
Previous $1.5 Million 19.16%
% of portfolio
0.99%
Previous 0.86%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
SELL
$66.59 - $83.99 $35,292 - $44,514
-530 Reduced 2.42%
21,377 $1.79 Million
Q2 2024

Aug 06, 2024
BUY
$63.15 - $72.88 $2,526 - $2,915
40 Added 0.18%
21,907 $1.5 Million
Q1 2024

Apr 26, 2024
BUY
$71.58 - $87.29 $73,083 - $89,123
1,021 Added 4.9%
21,867 $1.6 Million
Q4 2023

Jan 17, 2024
BUY
$73.27 - $83.09 $4,396 - $4,985
60 Added 0.29%
20,846 $1.69 Million
Q3 2023

Oct 19, 2023
BUY
$73.94 - $80.67 $33,273 - $36,301
450 Added 2.21%
20,786 $1.56 Million
Q2 2023

Jul 20, 2023
BUY
$76.01 - $86.7 $6,080 - $6,936
80 Added 0.39%
20,336 $1.57 Million
Q1 2023

Apr 28, 2023
BUY
$77.31 - $88.08 $88,906 - $101,292
1,150 Added 6.02%
20,256 $1.68 Million
Q4 2022

Jan 11, 2023
SELL
$62.32 - $89.47 $28,044 - $40,261
-450 Reduced 2.3%
19,106 $0
Q3 2022

Oct 19, 2022
BUY
$59.54 - $68.01 $38,701 - $44,206
650 Added 3.44%
19,556 $1.21 Million
Q2 2022

Jul 22, 2022
SELL
$57.72 - $65.01 $77,575 - $87,373
-1,344 Reduced 6.64%
18,906 $1.17 Million
Q1 2022

Apr 26, 2022
BUY
$57.92 - $72.58 $4,923 - $6,169
85 Added 0.42%
20,250 $1.2 Million
Q4 2021

Jan 21, 2022
BUY
$64.88 - $73.64 $1,557 - $1,767
24 Added 0.12%
20,165 $1.46 Million
Q3 2021

Oct 28, 2021
SELL
$67.69 - $73.03 $8,461 - $9,128
-125 Reduced 0.62%
20,141 $1.41 Million
Q2 2021

Aug 03, 2021
BUY
$63.47 - $69.35 $13,074 - $14,286
206 Added 1.03%
20,266 $1.4 Million
Q1 2021

Apr 30, 2021
BUY
$60.0 - $68.46 $5,880 - $6,709
98 Added 0.49%
20,060 $1.3 Million
Q4 2020

Jan 13, 2021
SELL
$56.65 - $64.55 $89,903 - $102,440
-1,587 Reduced 7.36%
19,962 $1.16 Million
Q3 2020

Oct 21, 2020
SELL
$62.1 - $78.08 $197,788 - $248,684
-3,185 Reduced 12.88%
21,549 $1.36 Million
Q2 2020

Jul 21, 2020
BUY
$72.34 - $84.0 $268,743 - $312,060
3,715 Added 17.67%
24,734 $1.9 Million
Q1 2020

May 07, 2020
SELL
$62.63 - $80.22 $24,989 - $32,007
-399 Reduced 1.86%
21,019 $1.57 Million
Q4 2019

Feb 10, 2020
SELL
$61.62 - $67.78 $30,686 - $33,754
-498 Reduced 2.27%
21,418 $1.39 Million
Q3 2019

Nov 05, 2019
SELL
$62.51 - $69.0 $18,815 - $20,769
-301 Reduced 1.35%
21,916 $1.39 Million
Q2 2019

Aug 07, 2019
SELL
$61.87 - $69.38 $13,673 - $15,332
-221 Reduced 0.98%
22,217 $1.5 Million
Q1 2019

Apr 29, 2019
SELL
$62.53 - $70.05 $51,587 - $57,791
-825 Reduced 3.55%
22,438 $1.46 Million
Q4 2018

Feb 01, 2019
SELL
$60.54 - $79.0 $47,826 - $62,410
-790 Reduced 3.28%
23,263 $1.46 Million
Q3 2018

Oct 25, 2018
SELL
$71.28 - $78.92 $35,283 - $39,065
-495 Reduced 2.02%
24,053 $1.86 Million
Q2 2018

Oct 19, 2018
SELL
$64.88 - $75.68 $8,758 - $10,216
-135 Reduced 0.55%
24,548 $1.74 Million
Q1 2018

Apr 12, 2018
BUY
$72.84 - $88.8 $26,440 - $32,234
363 Added 1.49%
24,683 $1.86 Million
Q4 2017

Feb 01, 2018
BUY
$71.15 - $83.52 $109,286 - $128,286
1,536 Added 6.74%
24,320 $1.74 Million
Q3 2017

Oct 23, 2017
BUY
$72.11 - $85.47 $1.64 Million - $1.95 Million
22,784
22,784 $1.85 Million

Others Institutions Holding GILD

# of Institutions
1,942
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Harrington Investments, Inc Portfolio

Follow Harrington Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harrington Investments, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email